✦ LIBER ✦

Presurgical (neoadjuvant) endocrine therapy is a useful model to predict response and outcome to endocrine treatment in breast cancer patients

✍ Scribed by Jürgen Geisler; Ian Smith; William Miller

Book ID: 116698755
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 740 KB
Volume: 131
Category: Article
ISSN: 0960-0760
DOI: 10.1016/j.jsbmb.2011.12.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

21-Gene expression profile assay on core

21-Gene expression profile assay on core needle biopsies predicts responses to neoadjuvant endocrine therapy in breast cancer patients

✍ Sadako Akashi-Tanaka; Chikako Shimizu; Masashi Ando; Tatsuhiro Shibata; Noriyuki 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 170 KB

P294 What is the key issue to evaluate a

P294 What is the key issue to evaluate adherence to endocrine treatment in breast cancer patients? Methodological results of a prospective study: Patient-reported outcomes in breast cancer patients undergoing endocrine therapy (PRO-BETh)

✍ R. Achleitner; A. Oberguggenberger; V. Meraner; C. Marth; B. Beer; J. Giesinger; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 52 KB

A prognostic model to predict outcome of

A prognostic model to predict outcome of patients failing to achieve pathological complete response after anthracycline-containing neoadjuvant chemotherapy for breast cancer

✍ Sheng Chen; Can-Ming Chen; Ke-Da Yu; Wen-Tao Yang; Zhi-Ming Shao 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 272 KB

Prediction of response to endocrine ther

Prediction of response to endocrine therapy in breast cancer using immunocytochemical assays for pS2, oestrogen receptor and progesterone receptor

✍ Y. A. Luqmani; D. Ricketts; G. Ryall; L. Turnbull; M. Law; R. C. Coombes 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 French ⚖ 802 KB

Histological sections obtained from 70 patients with breast cancer, all of whom had received endocrine therapy for metastatic or locally advanced disease, were assessed for specific immunocytochemical staining of oestrogen receptor and the oestrogen-induced protein pS2. There was also sufficient mat

Phase II trial with letrozole (2.5 mg) t

Phase II trial with letrozole (2.5 mg) to maximal response as neoadjuvant endocrine therapy in postmenopausal patients with ER/PgR[+] operable breast cancer

✍ A. Llombart; Galán; C. Fuster; E. Buch; V. Carañana; A. Rodriguez-Lescure; C. Vá 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Relationship between estrogen receptor v

Relationship between estrogen receptor values and clinical data in predicting the response to endocrine therapy for patients with advanced breast cancer

✍ David P. Byar; Mary E. Sears; William L. McGuire 📂 Article 📅 1979 🏛 Elsevier Science ⚖ 811 KB